Literature DB >> 18495207

The spectrum of histologic changes in thyroid hyperplasia: a clinicopathologic study of 300 cases.

Maria Delia Perez-Montiel1, Saul Suster.   

Abstract

Thyroid hyperplasia is a physiologic response of follicular epithelium to hormonal changes that result in disturbances in the feedback mechanism of thyrotropin-releasing hormone and thyroid-stimulating hormone. The most common manifestation of this process is the so-called sporadic goiter (diffuse or nodular hyperplasia), a condition that may be associated with a variety of stimuli. Some of the histologic changes that can be observed in hyperplasia of the thyroid can sometimes lead to an incorrect diagnosis of malignancy. We studied 300 consecutive cases of hyperplasia of the thyroid to evaluate morphologic features that could potentially be mistaken for neoplastic conditions. Florid papillary hyperplasia of follicular epithelium was observed in 13% of cases, in several instances closely resembling the papillary structures of papillary thyroid carcinoma. Foci displaying nuclear clearing closely resembling "Orphan-Annie" nuclei were present in 15% of cases. Nuclear grooves and pseudonuclear inclusions were also identified focally in 8% of cases. Cytologic atypia was observed in 7% of cases, including nuclear enlargement, multinucleation, and nuclear pleomorphism with prominent nucleoli. Mitoses were observed in 6% of cases and averaged 1 to 2 per 20 high-power fields. This finding was usually seen in the more cellular areas in cases characterized by a solid, microfollicular pattern of growth. Psammoma bodies were observed focally in 4 cases (1.3%). Infiltration of adjacent skeletal muscle by benign hyperplastic follicles was seen in 3 cases (1%). Another unexpected finding in 2 cases was the identification of small clusters of normal thyroid follicles within the sinuses of lymph nodes located adjacent to the gland (>1%). The present study confirms that thyroid hyperplasia can sometimes display features that may be confused for a malignant neoplastic process. Awareness of such features and their recognition are of importance to avoid a misdiagnosis of malignancy.

Entities:  

Mesh:

Year:  2008        PMID: 18495207     DOI: 10.1016/j.humpath.2007.12.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Cytopathological review of patients that underwent thyroidectomies based on the diagnosis of papillary thyroid carcinoma by fine needle aspiration cytology but were later found to have benign tumors by histopathology.

Authors:  Mutsukazu Kitano; Iwao Sugitani; Kazuhisa Toda; Motoko Ikenaga; Noriko Motoi; Noriko Yamamoto; Muneki Hotomi; Yoshihide Fujimoto; Kazuyoshi Kawabata
Journal:  Surg Today       Date:  2012-10-18       Impact factor: 2.549

Review 2.  Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists.

Authors:  Raja R Seethala; Zubair W Baloch; Justine A Barletta; Elham Khanafshar; Ozgur Mete; Peter M Sadow; Virginia A LiVolsi; Yuri E Nikiforov; Giovanni Tallini; Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-10-20       Impact factor: 7.842

3.  Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma.

Authors:  Juliette Hommell-Fontaine; Angela Borda; Florence Ragage; Nicole Berger; Myriam Decaussin-Petrucci
Journal:  Virchows Arch       Date:  2010-04-23       Impact factor: 4.064

4.  Histopathological Changes of the Thyroid and Parathyroid Glands in HIV-Infected Patients.

Authors:  Rabia Cherqaoui; K M Mohamed Shakir; Babak Shokrani; Sujay Madduri; Faria Farhat; Vinod Mody
Journal:  J Thyroid Res       Date:  2014-01-22

5.  Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma.

Authors:  Bo Zhang; Hui-Min Niu; Qiong Wu; Jiong Zhou; Yu-Xin Jiang; Xiao Yang; Jian-Chu Li; Rui-Na Zhao; Ming Wang; Kang-Ning Li; Shen-Ling Zhu; Yu Xia; Ding-Rong Zhong
Journal:  Chin Med J (Engl)       Date:  2016-01-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.